EUVIMED · CrossrefZeitschrift
Gastric Cancer
ISSN 1436-3291 · Springer Science and Business Media LLC
Neueste Artikel
Clinical impact of additional gastrectomy for endoscopic curability C-2 lesions after endoscopic submucosal dissection: a competing-risk analysis
Global population-based prevalence of genetic carriers of CDH1-associated hereditary diffuse gastric cancer
Beyond CDH1: expanded multigene testing reveals additional predisposition genes in hereditary gastric cancer in Brazil
Systemic and omental immune dysregulation associated with recurrence risk in gastric cancer
Robotic versus laparoscopic gastrectomy for gastric cancer: 5-year long-term results from a randomized controlled trial
Investigating the association between individual income and cancer outcomes among Canadians diagnosed with gastric cancer
Gastric cancer biomarker testing in Japan: a second nationwide survey of testing practices and associations with testing location
Beyond 30-day mortality: causes and risk factors of half-year postdischarge mortality after gastric cancer surgery
Comparison of geriatric assessment with provider’s clinical assessment among older adults with gastroesophageal cancer
Comparison of surgical outcomes in laparoscopic gastrectomy for advanced gastric cancer between Japanese and Italian cohorts: an international, propensity score-matched investigation (the Shinkansen Study)
Correction: Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G
Mesenchymal R-spondin 3 promotes an immunogenic tumor microenvironment with adaptive immune resistance in human gastric adenocarcinoma
Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809)
Correction: Identification of patients at risk for poor survival among those with normal skeletal muscle mass: a multicenter retrospective validation study in gastric cancer
Correction: Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects
Prognosis-predicting factor of gastrectomy after systemic cancer therapy for cStage IVB gastric cancer
Clinical impact of CT-defined sarcopenia on long-term oncological outcomes in gastric cancer: validation of muscle mass cut-offs established according to EWGSOP recommendations
Sensitivity and specificity of endoscopic and radiographic screening for localized gastric cancer in a real-world, population-based setting
External validation and comparison of five prediction models for lymph node metastasis after noncurative endoscopic submucosal dissection for early gastric cancer
A multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901)
Screening strategies for the early detection of non-cardia gastric cancer in low- to moderate-prevalence regions: Asia-Pacific gastroesophageal cancer congress consensus 2026
Clinicopathological characterization of extremely low-grade fundic gland tumors: a study of 11 of a variant of oxyntic gland adenomas
IGF2-associated tumor cells and APOE-positive macrophages define an imatinib resistance-associated niche in gastrointestinal stromal tumors
From operating room to pathology report: Delphi consensus on pathological assessment of peritoneal cytology and biopsies in staging laparoscopy for gastric cancer
Longitudinal assessment of quality-of-life after gastrectomy for gastric cancer: a prospective study
A preoperative risk-scoring model for predicting intraoperative hemorrhage during endoscopic submucosal dissection for gastric neoplasms
Lipidomic profiling of peritoneal lavage supernatant identifies PE/PA/PI-enriched recurrence biomarkers in cytology-negative gastric cancer
Acknowledgment to Reviewers
Clinical outcomes and germline implications of primary KIT exon 13 and 17 mutations in gastrointestinal stromal tumors
EUVIMED